A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products
NCT ID: NCT05394324
Last Updated: 2025-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1674 participants
OBSERVATIONAL
2022-06-21
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study Comparing Postoperative Outcomes Between the TECNIS Intraocular Lens.
NCT05396599
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
NCT06333015
Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants
NCT07213167
Clinical Performance of a Phakic Intraocular Lens (IOL)
NCT03499821
Objective and Subjective Evaluation of Ophthalmic Lenses With Extra Power
NCT05089240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
No study treatments will be administered during this retrospective study. However, data will be collected from medical records of patients who have been treated with subject devices of this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Status post ophthalmic surgery between 1 day and 24 months for Year 1. Subsequent years after Year 1 will be between 1 day and 18 months.
Exclusion Criteria
2. Use of surgical devices not in accordance with the product labeling or indications for use
3. Degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that cause visual acuity losses to a level worse than 0.2 logMAR (0.63 decimal, 6/9.5 or 20/32 Snellen) during the retrospective data collection period
4. Use of systemic or ocular medications that may affect vision during the retrospective data collection period
5. Known ocular disease or pathology that, in the opinion of the investigator may confound study findings during the retrospective data collection period
6. Pregnancy, lactating, or other condition associated with hormonal fluctuation that could lead to refractive changes during the retrospective data collection period.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Surgical Vision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johnson & Johnson Surgical Vision, Inc. Clinical Trial
Role: STUDY_DIRECTOR
Johnson & Johnson Surgical Vision, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Trinity Research Group, LLC
Dothan, Alabama, United States
Empire Eye and Laser Center
Bakersfield, California, United States
Chu Vision Institute
Bloomington, Minnesota, United States
Valley Retina Institute
McAllen, Texas, United States
Augenaerzte Gerl & Kollegen MVZ Ahaus GmbH
Ahaus, North Rhine-Westphalia, Germany
Augenzentrum Erzgebirge
Zschopau, Saxony, Germany
Augentagesklinik Spreebogen Berlin GbR
Berlin, , Germany
Clinica Vistahermosa
Alicante, Alacant, Spain
Hospital La Arruzafa
Córdoba, Andalusia, Spain
Instituto Universitario de Oftalmobiologia Aplicada
Valladolid, CL, Spain
Hosp. De La Santa Creu I Sant Pau
Barcelona, CT, Spain
Hospital Clinico San Carlos
Madrid, MD, Spain
Clinica Oftalvist
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JJSV301PMCF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.